BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1526199)

  • 1. BrdUrd/DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells.
    Demarcq C; Bastian G; Remvikos Y
    Cytometry; 1992; 13(4):416-22. PubMed ID: 1526199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.
    Fujikane T; Shimizu T; Tsuji T; Ishida S; Ohsaki Y; Onodera S
    Cytometry; 1989 Nov; 10(6):788-95. PubMed ID: 2582970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells.
    Sorenson CM; Eastman A
    Cancer Res; 1988 Dec; 48(23):6703-7. PubMed ID: 3180081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of an S phase population of cells without DNA synthesis generated by cisplatin and pentoxifylline.
    Perras JP; Ramos R; Sevin BU
    Cytometry; 1993; 14(4):441-8. PubMed ID: 8513698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks.
    Sorenson CM; Eastman A
    Cancer Res; 1988 Aug; 48(16):4484-8. PubMed ID: 3395999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
    Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC
    Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of cell proliferation kinetics and the effects of cisplatin on the cell cycle of human gastric cancer cells by autostage cytofluorometry].
    Azumi Y; Konishi E; Urata Y; Itoi H; Yamaguchi N; Kubo H; Horii A; Yamagishi H; Ashihara T; Oka T
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):987-92. PubMed ID: 1626956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
    Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens.
    ten Velde GP; Schutte B; Reijnders MM; Bosman FT; Blijham GH
    Cytometry; 1989 Nov; 10(6):807-10. PubMed ID: 2582973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cytokinetic response of human colon cancer cells to cis-dichlorodiammineplatinum(II).
    Bergerat JP; Barlogie B; Göhde W; Johnston DA; Drewinko B
    Cancer Res; 1979 Nov; 39(11):4356-63. PubMed ID: 498069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells.
    Liebmann JE; Fisher J; Teague D; Cook JA
    Oncol Res; 1994; 6(1):25-31. PubMed ID: 7919549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.
    Fram RJ; Woda BA; Wilson JM; Robichaud N
    Cancer Res; 1990 Jan; 50(1):72-7. PubMed ID: 2293559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between morphological manifestations and cell kinetic changes of human lung cancer cells after exposure to chemotherapeutic agents].
    Ito M
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):718-36. PubMed ID: 2430876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-phase arrest of nutrient deprived lung cancer cells.
    Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
    Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle traverse in AHH-1 tk +/- human lymphoblastoid cells exposed to the chromosomal mutagen, m-amsa.
    Morris SM; McGarrity LJ; Domon OE; Chen JJ; Casciano DA
    Environ Mol Mutagen; 1996; 27(1):10-8. PubMed ID: 8625943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell line and schedule-dependent cytotoxicity of paclitaxel (Taxol): role of the solvent Cremophor EL/ethanol.
    Cordes N; Plasswilm L
    Anticancer Res; 1998; 18(3A):1851-7. PubMed ID: 9673415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer chemo-endocrine therapy and its cell biological basis].
    Nishiya I
    Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between DNA replication and expression of cyclins A and B1 in individual MOLT-4 cells.
    Juan G; Li X; Darzynkiewicz Z
    Cancer Res; 1997 Mar; 57(5):803-7. PubMed ID: 9041174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.